AAAAAA

   
Results: 1-19 |
Results: 19
FUNCTIONAL-STUDIES OF 12 MUTANT V-2 VASOPRESSIN RECEPTORS RELATED TO NEPHROGENIC DIABETES-INSIPIDUS - MOLECULAR-BASIS OF A MILD CLINICAL PHENOTYPE
Authors: ALA Y MORIN D MOUILLAC B SABATIER N VARGAS R COTTE N DECHAUX M ANTIGNAC C ARTHUS MF LONERGAN M TURNER MS BALESTRE MN ALONSO G HIBERT M BARBERIS C HENDY GN BICHET DG JARD S
Citation: Y. Ala et al., FUNCTIONAL-STUDIES OF 12 MUTANT V-2 VASOPRESSIN RECEPTORS RELATED TO NEPHROGENIC DIABETES-INSIPIDUS - MOLECULAR-BASIS OF A MILD CLINICAL PHENOTYPE, Journal of the American Society of Nephrology, 9(10), 1998, pp. 1861-1872
IDENTIFICATION OF RESIDUES RESPONSIBLE FOR THE SELECTIVE BINDING OF PEPTIDE ANTAGONISTS AND AGONISTS IN THE V2 VASOPRESSIN RECEPTOR
Authors: COTTE N BALESTRE MN PHALIPOU S HIBERT M MANNING M BARBERIS C MOUILLAC B
Citation: N. Cotte et al., IDENTIFICATION OF RESIDUES RESPONSIBLE FOR THE SELECTIVE BINDING OF PEPTIDE ANTAGONISTS AND AGONISTS IN THE V2 VASOPRESSIN RECEPTOR, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 126-126
IDENTIFICATION OF RESIDUES RESPONSIBLE FOR THE SELECTIVE BINDING OF PEPTIDE ANTAGONISTS AND AGONISTS IN THE V2 VASOPRESSIN RECEPTOR
Authors: COTTE N BALESTRE MN PHALIPOU S HIBERT M MANNING M BARBERIS C MOUILLAC B
Citation: N. Cotte et al., IDENTIFICATION OF RESIDUES RESPONSIBLE FOR THE SELECTIVE BINDING OF PEPTIDE ANTAGONISTS AND AGONISTS IN THE V2 VASOPRESSIN RECEPTOR, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 1611-1611
INHIBITION OF OXYTOCIN RECEPTOR FUNCTION BY DIRECT BINDING OF PROGESTERONE
Authors: GRAZZINI E GUILLON G MOUILLAC B ZINGG HH
Citation: E. Grazzini et al., INHIBITION OF OXYTOCIN RECEPTOR FUNCTION BY DIRECT BINDING OF PROGESTERONE, Nature, 392(6675), 1998, pp. 509-512
STRUCTURAL BASES OF VASOPRESSIN OXYTOCIN RECEPTOR FUNCTION/
Authors: BARBERIS C MOUILLAC B DURROUX T
Citation: C. Barberis et al., STRUCTURAL BASES OF VASOPRESSIN OXYTOCIN RECEPTOR FUNCTION/, Journal of Endocrinology, 156(2), 1998, pp. 223-229
IDENTIFICATION OF RESIDUES RESPONSIBLE FOR THE SELECTIVE BINDING OF PEPTIDE ANTAGONISTS AND AGONISTS IN THE V2 VASOPRESSIN RECEPTOR
Authors: COTTE N BALESTRE MN PHALIPOU S HIBERT M MANNING M BARBERIS C MOUILLAC B
Citation: N. Cotte et al., IDENTIFICATION OF RESIDUES RESPONSIBLE FOR THE SELECTIVE BINDING OF PEPTIDE ANTAGONISTS AND AGONISTS IN THE V2 VASOPRESSIN RECEPTOR, The Journal of biological chemistry, 273(45), 1998, pp. 29462-29468
MAPPING PEPTIDE-BINDING DOMAINS OF THE HUMAN V1A VASOPRESSIN RECEPTORWITH A PHOTOACTIVATABLE LINEAR PEPTIDE ANTAGONIST
Authors: PHALIPOU S COTTE N CARNAZZI E SEYER R MAHE E JARD S BARBERIS C MOUILLAC B
Citation: S. Phalipou et al., MAPPING PEPTIDE-BINDING DOMAINS OF THE HUMAN V1A VASOPRESSIN RECEPTORWITH A PHOTOACTIVATABLE LINEAR PEPTIDE ANTAGONIST, The Journal of biological chemistry, 272(42), 1997, pp. 26536-26544
PROPERTIES OF A NEW RADIOIODINATED ANTAGONIST FOR HUMAN VASOPRESSIN V-2 AND V-1A RECEPTORS
Authors: ALA Y MORIN D MAHE E COTTE N MOUILLAC B JARD S BARBERIS C TRIBOLLET E DREIFUSS JJ SAWYER WH WO NC CHAN WY KOLODZIEJCZYK AS CHENG LL MANNING M
Citation: Y. Ala et al., PROPERTIES OF A NEW RADIOIODINATED ANTAGONIST FOR HUMAN VASOPRESSIN V-2 AND V-1A RECEPTORS, European journal of pharmacology, 331(2-3), 1997, pp. 285-293
INFLUENCE OF RECEPTOR DENSITY ON THE PATTERNS OF BETA(2)-ADRENOCEPTORDESENSITIZATION
Authors: ROUSSEAU G GUILBAULT N DASILVA A MOUILLAC B CHIDIAC P BOUVIER M
Citation: G. Rousseau et al., INFLUENCE OF RECEPTOR DENSITY ON THE PATTERNS OF BETA(2)-ADRENOCEPTORDESENSITIZATION, European journal of pharmacology, 326(1), 1997, pp. 75-84
EFFICIENT PHOTOAFFINITY-LABELING OF THE RAT V-1A VASOPRESSIN RECEPTORUSING A LINEAR AZIDOPEPTIDIC ANTAGONIST
Authors: CARNAZZI E AUMELAS A PHALIPOU S MOUILLAC B GUILLON G BARBERIS C SEYER R
Citation: E. Carnazzi et al., EFFICIENT PHOTOAFFINITY-LABELING OF THE RAT V-1A VASOPRESSIN RECEPTORUSING A LINEAR AZIDOPEPTIDIC ANTAGONIST, European journal of biochemistry, 247(3), 1997, pp. 906-913
PALMITOYLATED CYSTEINE-341 MODULATES PHOSPHORYLATION OF THE BETA(2)-ADRENERGIC RECEPTOR BY THE CAMP-DEPENDENT PROTEIN-KINASE
Authors: MOFFETT S ADAMS L BONIN H LOISEL TP BOUVIER M MOUILLAC B
Citation: S. Moffett et al., PALMITOYLATED CYSTEINE-341 MODULATES PHOSPHORYLATION OF THE BETA(2)-ADRENERGIC RECEPTOR BY THE CAMP-DEPENDENT PROTEIN-KINASE, The Journal of biological chemistry, 271(35), 1996, pp. 21490-21497
2 AROMATIC RESIDUES REGULATE THE RESPONSE OF THE HUMAN OXYTOCIN RECEPTOR TO THE PARTIAL AGONIST ARGININE-VASOPRESSIN
Authors: CHINI B MOUILLAC B BALESTRE MN TRUMPPKALLMEYER S HOFLACK J HIBERT M ANDRIOLO M PUPIER S JARD S BARBERIS C
Citation: B. Chini et al., 2 AROMATIC RESIDUES REGULATE THE RESPONSE OF THE HUMAN OXYTOCIN RECEPTOR TO THE PARTIAL AGONIST ARGININE-VASOPRESSIN, FEBS letters, 397(2-3), 1996, pp. 201-206
THE BETA(2)-ADRENERGIC RECEPTOR - STUDY M ODEL FOR AGONIST-INDUCED DESENSITIZATION
Authors: BOUVIER M NANTEL F VALIQUETTE M MOFFETT S MOUILLAC B
Citation: M. Bouvier et al., THE BETA(2)-ADRENERGIC RECEPTOR - STUDY M ODEL FOR AGONIST-INDUCED DESENSITIZATION, MS. Medecine sciences, 11(6), 1995, pp. 819-827
PALMITOYLATION OF G-PROTEIN-COUPLED RECEPTORS - A DYNAMIC MODIFICATION WITH FUNCTIONAL CONSEQUENCES
Authors: BOUVIER M MOFFETT S LOISEL TP MOUILLAC B HEBERT T CHIDIAC P
Citation: M. Bouvier et al., PALMITOYLATION OF G-PROTEIN-COUPLED RECEPTORS - A DYNAMIC MODIFICATION WITH FUNCTIONAL CONSEQUENCES, Biochemical Society transactions, 23(1), 1995, pp. 116-120
TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR
Authors: CHINI B MOUILLAC B ALA Y BALESTRE MN TRUMPPKALLMEYER S HOFLACK J ELANDS J HIBERT M MANNING M JARD S BARBERIS C
Citation: B. Chini et al., TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR, EMBO journal, 14(10), 1995, pp. 2176-2182
3D MODELS OF HORMONE RECEPTORS - EXPERIMENTAL VALIDATION
Authors: HIBERT M HOFLACK J TRUMPPKALLMEYER S PAQUET JL LEPPIK R BARBERIS C MOUILLAC B CHINI B JARD S
Citation: M. Hibert et al., 3D MODELS OF HORMONE RECEPTORS - EXPERIMENTAL VALIDATION, European journal of medicinal chemistry, 30, 1995, pp. 189-199
THE BINDING-SITE OF NEUROPEPTIDE VASOPRESSIN V1A RECEPTOR - EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS
Authors: MOUILLAC B CHINI B BALESTRE MN ELANDS J TRUMPPKALLMEYER S HOFLACK J HIBERT M JARD S BARBERIS C
Citation: B. Mouillac et al., THE BINDING-SITE OF NEUROPEPTIDE VASOPRESSIN V1A RECEPTOR - EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS, The Journal of biological chemistry, 270(43), 1995, pp. 25771-25777
DESENSITIZATION, PHOSPHORYLATION AND PALMITOYLATION OF THE HUMAN DOPAMINE-D1 RECEPTOR
Authors: NG GYK MOUILLAC B GEORGE SR CARON M DENNIS M BOUVIER M ODOWD BF
Citation: Gyk. Ng et al., DESENSITIZATION, PHOSPHORYLATION AND PALMITOYLATION OF THE HUMAN DOPAMINE-D1 RECEPTOR, European journal of pharmacology. Molecular pharmacology section, 267(1), 1994, pp. 7-19
PALMITOYLATION OF THE BETA-2-ADRENERGIC RECEPTOR MODULATES ITS PHOSPHORYLATION AND RESPONSIVENESS
Authors: BOUVIER M MOFFETT S MOUILLAC B
Citation: M. Bouvier et al., PALMITOYLATION OF THE BETA-2-ADRENERGIC RECEPTOR MODULATES ITS PHOSPHORYLATION AND RESPONSIVENESS, The FASEB journal, 7(7), 1993, pp. 1047-1047
Risultati: 1-19 |